Qin Ning

Active 1997–2026

101
Papers
19,080
Citations
49
h-index
96
i10-index

Citations

Citations per year for Qin Ning1992: 1 citations1998: 3 citations1999: 4 citations2000: 11 citations2001: 12 citations2002: 7 citations2003: 10 citations2004: 12 citations2005: 10 citations2006: 8 citations2007: 9 citations2008: 12 citations2009: 13 citations2010: 26 citations2011: 21 citations2012: 26 citations2013: 29 citations2014: 18 citations2015: 31 citations2016: 20 citations2017: 48 citations2018: 59 citations2019: 249 citations2020: 2,551 citations2021: 1,804 citations2022: 907 citations2023: 461 citations2024: 670 citations2025: 266 citations2026: 16 citations1993–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,809 citing papers, 17.2% of this breakdownChina: 1,790 citing papers, 17% of this breakdownUnited Kingdom: 580 citing papers, 5.5% of this breakdownItaly: 540 citing papers, 5.1% of this breakdownIndia: 470 citing papers, 4.5% of this breakdownGermany: 383 citing papers, 3.6% of this breakdownSpain: 344 citing papers, 3.3% of this breakdownFrance: 331 citing papers, 3.1% of this breakdownCanada: 308 citing papers, 2.9% of this breakdownAustralia: 226 citing papers, 2.2% of this breakdownBrazil: 213 citing papers, 2% of this breakdownIran: 193 citing papers, 1.8% of this breakdown
0%17.2%Other 31.8%

Fields

  • Medicine81.9%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology5.4%
  • Neuroscience1.1%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Nursing0.8%
  • Other3.2%

Topics

  • COVID-19 Clinical Research Studies17%
  • Long-Term Effects of COVID-1910.6%
  • SARS-CoV-2 and COVID-19 Research7.1%
  • Liver Disease Diagnosis and Treatment3%
  • Liver Disease and Transplantation2.6%
  • Hepatitis B Virus Studies2.4%
  • Other57.3%

Coauthors

All papers

Open in search
  1. Clinical and immunological features of severe and moderate coronavirus disease 2019

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 5,074

  2. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal and 12 more - Hepatology International 2019 cited by 889

  3. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

    Authors: , , , , , , , , , , , , , , , , , , , , - BMJ 2020 cited by 4,159

  4. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brajesh Chander Sharma, Manoj Kumar Sharma, Kapil Sharma, Amna Subhan Butt, Soek Siam Tan, Chitranshu Vashishtha, Zeeshan Ahmad Wani, Man‐Fung Yuen, Osamu Yokosuka, the APASL ACLF Working Party - Hepatology International 2014 cited by 1,496

  5. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2021 cited by 244

  6. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism

    Authors: , , , , , , , , , , - Nature Communications 2017 cited by 187

  7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder

    Authors: , , , , , , , , , , - Theranostics 2020 cited by 105

  8. Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2016 cited by 261

  9. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB

    Authors: , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 100

  10. Acute liver failure: mechanisms of immune-mediated liver injury

    Authors: , , , , - Liver International 2010 cited by 281

  11. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 cited by 83

  12. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations

    Authors: , , , , , , , , , , , , , , , - JCI Insight 2022 cited by 89

  13. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

    Authors: , , , , , , , , - Journal of Hepatology 2014 cited by 279

  14. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana A. Payawal, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, George Lau, Fazal Karim, Padaki Nagaraja Rao, Richard Moreau, Pratik Jain, P. Bhatia, G. Kumar, Shiv Kumar Sarin - Hepatology International 2017 cited by 220

  15. Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

    Authors: , , , , , , - Frontiers in Immunology 2023 cited by 47

  16. FGL2–MCOLN3-Autophagy Axis–Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis

    Authors: , , , , , , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2022 cited by 43

  17. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2008 cited by 762

  18. The role of B cells in COVID-19 infection and vaccination

    Authors: , , , , , , , , , , , - Frontiers in Immunology 2022 cited by 79

  19. Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Liver International 2021 cited by 59

  20. Circulating MOTS-c levels are decreased in obese male children and adolescents and associated with insulin resistance

    Authors: , , , , , , , , , - Pediatric Diabetes 2018 cited by 95

  21. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

    Authors: , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 cited by 85

  22. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

    Authors: , , , , , , , , , , - Critical Care 2020 cited by 198

  23. Trimetazidine prevents macrophage‐mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1

    Authors: , , , , , , , - British Journal of Pharmacology 2015 cited by 123

  24. Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peng Hu, Pisit Tangkijvanich, Lunli Zhang, Zhi Gao, Feng Lin, Thi Tuyet Phuong Le, Jia Shang, Guozhong Gong, Jun Li, Minghua Su, Zhongping Duan, Rosmawati Mohamed, Jin Hou, Jidong Jia - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 120